Events & News

AiCure and Defense Health Agency to Develop Targeted PTSD Treatment for Service Members and Veterans

AiCure, an artificial intelligence (AI) and advanced data analytics company focused on improving clinical trials, today announced the DHA PTSD-DT Program will deploy AiCure’s AI platform in its post-traumatic stress disorder (PTSD) adaptive platform trial (APT) to simultaneously evaluate the…

Demystifying Machine Learning: Why Transparency Will Lead to Trust

PharmaLeaders published…

Woman of the Week: AiCure’s Michelle Marlborough

AiCure’s Chief Product Officer Michelle Marlborough is PharmaVoice’s Woman of the Week.

The Pulse of Rare Disease Support – Pharmaceutical Commerce

Pharmaceutical Commerce highlighted AiCure’s Chief Medical Officer, Dr. Rich Christie’s insights around the use of digital biometrics for patient support.

AiCure Bolsters Global Presence and Team to Expand its Reach and Foster Diverse Perspectives

AiCure, an AI and advanced data analytics company focused on improving clinical trials, today announced it is expanding its global…
AI in Oncology Trials

The Role of AI in Precision Medicine: The Right Drug for the Right Patient at the Right Time – PharmaLeaders

PharmaLeaders published “The Role of AI in Precision Medicine: The Right Drug for the Right Patient at the…
AI for Dose Adherence

Trendspotting: What’s Coming for Bio-IT in 2022 – Bio-IT World

Bio-IT World published their 2022 predictions round-up, “Trendspotting: What’s Coming for Bio-IT in 2022,” featuring insights from …
Artificial Intelligence in Clinical Trials

We Recall Drugs with Adverse Effects, So Why Not Recall AI Algorithms with Racial Bias? – HIT Consultant

HIT Consultant featured AiCure CEO Ed Ikeguchi in the article, “We Recall Drugs with Adverse Effects, So Why Not…
Good Machine Learning Practice

The Defining AI Trends of 2022 – Applied Clinical Trials

ACT featured Ed Ikeguchi’s predictions in a stand-alone piece, “The Defining AI Trends of 2022,” illustrating the importance…